Inclusion Criteria:

• Age 21 years or older.
• Presence of severe degenerative mitral regurgitation confirmed by echocardiography.
• Mitral leaflet anatomy suitable for coaptation to allow reduction of mitral regurgitation without undue leaflet tension.
• Ability to provide informed consent and willingness to comply with study procedures and follow-up.

Exclusion Criteria:

• Functional mitral regurgitation.
• Severe mitral annular or leaflet calcification.
• Significant concomitant valvular disease (e.g., severe aortic stenosis or insufficiency, severe tricuspid regurgitation).
• Left ventricular ejection fraction <30% or severe right ventricular dysfunction.
• Requirement for concomitant cardiac surgery.
• Prior cardiac valve intervention or structural heart procedure (excluding prior PCI).
• Recent major cardiovascular events (e.g., stroke or myocardial infarction within 30 days).
• Hemodynamic instability or cardiogenic shock at the time of enrollment.
• Significant comorbid conditions that increase procedural risk, including advanced liver disease, severe hematologic abnormalities, or active infection.
• Contraindications to study procedures or required medications, including inability to tolerate anticoagulation or transesophageal echocardiography.
• Pregnancy, lactation, or planned pregnancy during the study period.
• Participation in another investigational device or drug study that could interfere with outcomes.
• Life expectancy less than 12 months or any condition that, in the opinion of the investigator, precludes study participation.